Study details
Enrolling now
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
University of California, Los Angeles
NCT IDNCT06597942ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Target enrollment
54
Study length
about 2 years
Ages
60–100
Locations
1 site in CA
About this study
Researchers are testing if deep repetitive transcranial magnetic stimulation (rTMS) targeting the precuneus can improve memory in people with probable Alzheimer's Dementia. The trial will compare active rTMS to a sham treatment, while also monitoring brain changes and memory function.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use TMS
- 2.Use Transcranial Magnetic Stimulation Sham
PhasePhase 1/Phase 2
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Adverse Events, resting-state functional MRI connectivity
Devices
therapeutic
Body systems
Neurology